F1000Res . Current situation of vaccine injury compensation program and a future perspective in light of COVID-19 and emerging viral diseases

[tetano]

F1000Res


. 2021 Jul 26;10:652.
doi: 10.12688/f1000research.51160.1. eCollection 2021.
Current situation of vaccine injury compensation program and a future perspective in light of COVID-19 and emerging viral diseases


Tommie Crum ¹ , Kirsten Mooney ¹ , Birendra R Tiwari ²



Affiliations

• PMID: 35035888
• PMCID: PMC8733825
• DOI: 10.12688/f1000research.51160.1

Abstract

Background: Vaccines have had a great impact on disease prevention and mortality reduction. Very rarely, vaccines also can result in serious adverse effects. In consideration of this fact, vaccine injury compensation programs have been implemented in many countries to compensate a vaccinee for associated adverse effects. The existing vaccine injury compensation system addresses routine immunization schemes. However, there are rising concerns about the compensation for adverse effects caused by new vaccines such as those developed for coronavirus disease 2019 (COVID-19). The objective of this article is to review the existing vaccine injury compensation programs in different countries. The review also highlights the necessity to include all upcoming new vaccines for COVID-19 and other emerging viral diseases in the compensation schemes. Methods : Published articles relating to vaccine compensation injury programs, vaccines, injuries, disabilities, illnesses, and deaths resulting from vaccination were searched in data bases. Through a careful review of the abstracts, 25 relevant articles were selected for analysis. Results: We identified 27 countries on four continents with vaccine injury compensation schemes: 17 countries in Europe, 7 countries in Asia, the United States, a Canadian Province and New Zealand. No programs were identified in Africa and in South America. Program design, funding, and eligibility for compensation vary vastly between countries. We identified 17 countries operating well-established vaccine injury compensation programs. However, minimal information is available on numerous other countries. Conclusion: We have identified 27 countries operating vaccine injury compensation programs. In Canada, Quebec is the only province with a scheme; however, discussions are ongoing in Canada for nationwide implementation in light of COVID 19. Study limitations include limited scientific material, which hindered our research. Additional data concerning payout for each type of injury and the number of claimants related to a specific vaccine injury worldwide could provide a more comprehensive analysis.

Keywords: COVID-19 vaccines; Immunization; Vaccine; Vaccine Injury Compensation Programs; emerging viral diseases.